ICMR Study shows shorter TB regimes are cost-effective in India
New Delhi: Six-month all-oral treatment regimens for multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) in India are not only cost-effective but also deliver improved health outcomes compared to the currently used longer…